These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
120 related items for PubMed ID: 15039298
1. Incorporation of an oxygen from water into troglitazone quinone by cytochrome P450 and myeloperoxidase. He K, Talaat RE, Woolf TF. Drug Metab Dispos; 2004 Apr; 32(4):442-6. PubMed ID: 15039298 [Abstract] [Full Text] [Related]
2. Metabolic activation of troglitazone: identification of a reactive metabolite and mechanisms involved. He K, Talaat RE, Pool WF, Reily MD, Reed JE, Bridges AJ, Woolf TF. Drug Metab Dispos; 2004 Jun; 32(6):639-46. PubMed ID: 15155556 [Abstract] [Full Text] [Related]
3. Troglitazone quinone formation catalyzed by human and rat CYP3A: an atypical CYP oxidation reaction. He K, Woolf TF, Kindt EK, Fielder AE, Talaat RE. Biochem Pharmacol; 2001 Jul 15; 62(2):191-8. PubMed ID: 11389877 [Abstract] [Full Text] [Related]
4. Electrochemical oxidation of troglitazone: identification and characterization of the major reactive metabolite in liver microsomes. Madsen KG, Grönberg G, Skonberg C, Jurva U, Hansen SH, Olsen J. Chem Res Toxicol; 2008 Oct 15; 21(10):2035-41. PubMed ID: 18788755 [Abstract] [Full Text] [Related]
5. Enzyme-induction dependent bioactivation of troglitazone and troglitazone quinone in vivo. Tettey JN, Maggs JL, Rapeport WG, Pirmohamed M, Park BK. Chem Res Toxicol; 2001 Aug 15; 14(8):965-74. PubMed ID: 11511170 [Abstract] [Full Text] [Related]
6. Production of a reactive metabolite of troglitazone by electrochemical oxidation performed in nonaqueous medium. Tahara K, Nishikawa T, Hattori Y, Iijima S, Kouno Y, Abe Y. J Pharm Biomed Anal; 2009 Dec 05; 50(5):1030-6. PubMed ID: 19581066 [Abstract] [Full Text] [Related]
7. Mechanistic studies on the metabolic scission of thiazolidinedione derivatives to acyclic thiols. Reddy VB, Karanam BV, Gruber WL, Wallace MA, Vincent SH, Franklin RB, Baillie TA. Chem Res Toxicol; 2005 May 05; 18(5):880-8. PubMed ID: 15892582 [Abstract] [Full Text] [Related]
8. Troglitazone thiol adduct formation in human liver microsomes: enzyme kinetics and reaction phenotyping. Gan J, Qu Q, He B, Shyu WC, Rodrigues AD, He K. Drug Metab Lett; 2008 Aug 05; 2(3):184-9. PubMed ID: 19356091 [Abstract] [Full Text] [Related]
9. Toxic metabolite formation from Troglitazone (TGZ): new insights from a DFT study. Dixit VA, Bharatam PV. Chem Res Toxicol; 2011 Jul 18; 24(7):1113-22. PubMed ID: 21657230 [Abstract] [Full Text] [Related]
10. Thiazolidinedione bioactivation: a comparison of the bioactivation potentials of troglitazone, rosiglitazone, and pioglitazone using stable isotope-labeled analogues and liquid chromatography tandem mass spectrometry. Alvarez-Sanchez R, Montavon F, Hartung T, Pähler A. Chem Res Toxicol; 2006 Aug 18; 19(8):1106-16. PubMed ID: 16918252 [Abstract] [Full Text] [Related]
11. NADPH-dependent covalent binding of [3H]paroxetine to human liver microsomes and S-9 fractions: identification of an electrophilic quinone metabolite of paroxetine. Zhao SX, Dalvie DK, Kelly JM, Soglia JR, Frederick KS, Smith EB, Obach RS, Kalgutkar AS. Chem Res Toxicol; 2007 Nov 18; 20(11):1649-57. PubMed ID: 17907785 [Abstract] [Full Text] [Related]
13. Oxidation of 9-alkylanthracenes by cytochrome P450 2B1, horseradish peroxidase, and iron tetraphenylporphine/iodosylbenzene systems: anaerobic and aerobic mechanisms. Anzenbacher P, Niwa T, Tolbert LM, Sirimanne SR, Guengerich FP. Biochemistry; 1996 Feb 27; 35(8):2512-20. PubMed ID: 8611554 [Abstract] [Full Text] [Related]
14. CYP2C8- and CYP3A-mediated C-demethylation of (3-{[(4-tert-butylbenzyl)-(pyridine-3-sulfonyl)-amino]-methyl}-phenoxy)-acetic acid (CP-533,536), an EP2 receptor-selective prostaglandin E2 agonist: characterization of metabolites by high-resolution liquid chromatography-tandem mass spectrometry and liquid chromatography/mass spectrometry-nuclear magnetic resonance. Prakash C, Wang W, O'Connell T, Johnson KA. Drug Metab Dispos; 2008 Oct 27; 36(10):2093-103. PubMed ID: 18653741 [Abstract] [Full Text] [Related]
16. Hepatobiliary disposition of troglitazone and metabolites in rat and human sandwich-cultured hepatocytes: use of Monte Carlo simulations to assess the impact of changes in biliary excretion on troglitazone sulfate accumulation. Lee JK, Marion TL, Abe K, Lim C, Pollock GM, Brouwer KL. J Pharmacol Exp Ther; 2010 Jan 27; 332(1):26-34. PubMed ID: 19801447 [Abstract] [Full Text] [Related]
18. Novel metabolic pathway of arylethers by cytochrome P450: cleavage of the oxygen-aromatic ring bond accompanying ipso-substitution by the oxygen atom of the active species in cytochrome P450 models and cytochrome P450. Ohe T, Mashino T, Hirobe M. Arch Biochem Biophys; 1994 May 01; 310(2):402-9. PubMed ID: 8179325 [Abstract] [Full Text] [Related]
19. In vitro metabolism study of combretastatin A-4 in rat and human liver microsomes. Aprile S, Del Grosso E, Tron GC, Grosa G. Drug Metab Dispos; 2007 Dec 01; 35(12):2252-61. PubMed ID: 17890446 [Abstract] [Full Text] [Related]
20. Identification of glutathione conjugates of troglitazone in human hepatocytes. Prabhu S, Fackett A, Lloyd S, McClellan HA, Terrell CM, Silber PM, Li AP. Chem Biol Interact; 2002 Nov 10; 142(1-2):83-97. PubMed ID: 12399157 [Abstract] [Full Text] [Related] Page: [Next] [New Search]